Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-08 11:02 am Purchase |
2009-02-28 | 13G | BioMarin Pharmaceutical Inc. BMRN |
PRIMECAP MANAGEMENT CO/CA/ | 18,205,334 10.030% |
57,373 (+0.32%) |
Filing History |
| 2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | BioMarin Pharmaceutical Inc. BMRN |
Capital Research Global Investors | 22,193,527 12.200% |
189,462 (+0.86%) |
Filing History |
| 2021-02-11 3:42 pm Purchase |
2020-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
Dodge & Cox | 9,796,924 5.400% |
9,796,924 (New Position) |
Filing History |
| 2021-02-10 10:39 am Sale |
2020-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
The Vanguard Group | 16,369,689 9.020% |
-167,091 (-1.01%) |
Filing History |
| 2021-02-05 08:03 am Purchase |
2020-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
BlackRock Inc. BLK |
14,766,892 8.100% |
1,700,689 (+13.02%) |
Filing History |
| 2021-01-07 09:56 am Sale |
2009-02-28 | 13G | BioMarin Pharmaceutical Inc. BMRN |
PRIMECAP MANAGEMENT CO/CA/ | 18,147,961 9.997% |
-38,750 (-0.21%) |
Filing History |
| 2020-09-10 12:00 pm Purchase |
2009-02-28 | 13G | BioMarin Pharmaceutical Inc. BMRN |
PRIMECAP MANAGEMENT CO/CA/ | 18,186,711 10.030% |
1,857,391 (+11.37%) |
Filing History |